Scaffold attachment region-containing retrovirus vectors improve long-term proviral expression after transplantation of GFP-modified CD34+ baboon repopulating cells

Blood

Volumn 102, Issue 9, 2003, Pages 3117-3119

  Kurre, Peter ^b   Morris, Julia ^b   Thomasson, Bobbie ^b   Kohn, Donald B ^b   Kiem, Hans Peter ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD34 ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; ENHANCED YELLOW FLUORESCENT PROTEIN; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; PROTEIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY COMBINING SITE; ANTIGEN EXPRESSION; ARTICLE; CELL LINEAGE; CELL POPULATION; CELL SELECTION; CELL TRANSPLANTATION; CONTROLLED STUDY; FLUORESCENCE; FOLLOW UP; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; GENE THERAPY; HEMATOPOIETIC CELL; IMMUNOMODULATION; INSERTIONAL MUTAGENESIS; MATRIX ATTACHMENT REGION; MULTICOPY INTEGRATION; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN MODIFICATION; PROVIRUS; RISK FACTOR; SIGNAL TRANSDUCTION; TRANSGENE; VIRUS EXPRESSION;

EID: 0142245611     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-03-0962     Document Type: Article

References (26)

1. Challita PM, Skelton D, el-Khoueiry A, Yu XJ, Weinberg K, Kohn DB. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J Virol. 1995;69:748-755.
2. Halene S, Wang L, Cooper RM, Bockstoce DC, Robbins PB, Kohn DB. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. Blood. 1999;94:3349-3357.
3. Kurre P, Morris J, Andrews RG, Kohn DB, Kiem HP. Kinetics of fluorescence expression in nonhuman primates transplanted with GFP retrovirus-modified CD34 cells. Mol Ther. 2002;6:83-90.
4. Schambach A, Wodrich H, Hildinger M, Bohne J, Krausslich HG, Baum C. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol Ther. 2000;2:435-445.
5. Murray L, Travis M, Luens-Abitorabi K, et al. Addition of the human interferon beta scaffold attachment region to retroviral vector backbones increases the level of in vivo transgene expression among progeny of engrafted human hematopoietic stem cells. Hum Gene Ther. 2000;11:2039-2050.
6. Emery DW, Yannaki E, Tubb J, Stamatoyannopoulos G. A chromatin insulator protects retrovirus vectors from chromosomal position effects. Proc Natl Acad Sci U S A. 2000;97:9150-9155.
7. Bode J, Schlake T, Rios-Ramirez M, et al. Scaffold/matrix-attached regions: structural properties creating transcriptionally active loci. Int Rev Cytol. 1995;162A:389-454.
8. Agarwal M, Austin TW, Morel F, Chen J, Bohnlein E, Plavec I. Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells. J Virol. 1998;72:3720-3728.
9. Austin TW, Moss K, Morel F, Plavec I. An improved vector for high-level, consistent retroviral transgene expression in human thymocytes after competitive reconstitution from transduced peripheral blood stem cells. Hum Gene Ther. 2001; t2:1239-1249.
10. Auten J, Agarwal M, Chen J, Sutton R, Plavec I. Effect of scaffold attachment region on transgene expression in retrovirus vector-transduced primary T cells and macrophages. Hum Gene Ther. 1999;10:1389-1399.
11. Kalberer CP, Pawliuk R, Imren S, et al. Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human beta-globin in engrafted mice. Proc Natl Acad Sci U S A. 2000;97:5411-5415.
12. Persons DA, Allay JA, Allay ER, et al. Retrovital-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood. 1997;90:1777-1786.
13. Pawliuk R, Eaves CJ, Humphries RK. Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen. Hum Gene Ther. 1997;8:1595-1604.
14. Kiem HP, Rasko JE, Morris J, Peterson L, Kurre P, Andrews RG. Ex vivo selection for oncoretrovirally transduced green fluorescent protein-expressing CD34-enriched cells increases short-term engraftment of transduced cells in baboons. Hum Gene Ther. 2002;13:891-899.
15. Kiem HP, Heyward S, Winkler A, et al. Gene transfer into marrow repopulating cells: comparison between amphotropic and gibbon ape leukemia virus pseudotyped retrovital vectors in a competitive repopulation assay in baboons. Blood. 1997;90:4638-4645.
16. Kiem HP, Andrews RG, Morris J, et al. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood. 1998;92:1878-1886.
17. Lutzko CHS, Senadheera D, Carbonaro D, Kohn DB. Addition of the B-interferon SAR leads to an orientation dependent increase in transgene expression in stem cells and their progeny. Mol Ther. 2002:7;s426.
18. Horn PA, Topp MS, Morris JC, Riddell SR, Kiem HP. Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells. Blood. 2002;100:3960-3967.
19. Kurre P, Morris J, Horn PA, Harkey MA, Andrews RG, Klem HP. Gene transfer into baboon repopulating cells: a comparison of Flt-3 ligand and megakaryocyte growth and development factor versus IL-3 during ex vivo transduction. Mol Ther. 2001;3:920-927.
20. Gothot A, van der Loo JC, Clapp DW, Srour EF.3 Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood. 1998;92:2641-2649.
21. Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential dudng their S/G(2)/M transit and do not reenter G(0). Blood. 2000;96:4185-4193.
22. Tisdale JF, Hanazono Y, Sellers SE, et al. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood. t998;92:tt3l-114t.
23. Rosenzweig M, MacVittie TJ, Harper D, et al. Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood. 1999;94:2271-2286.
24. Mielke C, Maass K, Tummler M, Bode J. Anatomy of highly expressing chromosomal sites targeted by retroviral vectors. Biochemistry. 1996;35:2239-2252.
25. Ramezani A, Hawley TS, Hawley RG. Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator. Blood. 2003;101:4717-4724.
26. Wahlers A, Schwieger M, Li Z, et al. Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoietic cells. Gene Ther. 2001;8:477-486.